Thursday, October 1, 2020
Home Tags Drug development

drug development Related News

First medicine to prolong survival in patients with chronic kidney disease

First medicine to prolong survival in patients with chronic kidney disease

In a groundbreaking Phase III trial AstraZeneca’s Farxiga has shown reduction in the risk of kidney failure and cardiovascular or renal death in patients...
Investigation launched after Home Office psilocybin rescheduling response

Investigation launched after Home Office psilocybin rescheduling response

MP Crispin Blunt has launched an economic investigation following the Home Office’s response to the recent call for the rescheduling of psilocybin. The non-profit Conservative...
First at-home treatment for spinal muscular atrophy approved by FDA

First at-home treatment for spinal muscular atrophy approved by FDA

The first at-home, orally administered treatment for spinal muscular atrophy has been approved by the US Food and Drug Administration (FDA). The treatment – Evrysdi...
The UK Vaccine Taskforce: securing access to vaccines

The UK Vaccine Taskforce: securing access to vaccines

Kate Bingham, Chair of the UK Vaccine Taskforce, discusses the three goals of the taskforce. The UK Vaccine Taskforce has three key goals: to secure...
Cannabinoid therapies aim to address unmet medical needs

Cannabinoid therapies aim to address unmet medical needs

Oxford Cannabinoid Technologies (OCT) has appointed a new Chief Scientific Officer to help deliver cannabinoid therapies for unmet medical needs. Dr Valentino Parravicini, PhD will...
Farxiga meets endpoints in trial for the treatment of chronic kidney disease

Farxiga meets endpoints in trial for the treatment of chronic kidney disease

Farxiga has been shown to significantly reduce the worsening of renal function or risk of death in patients with chronic kidney disease with and...
Farxiga granted Fast Track Designation for heart failure treatment

Farxiga granted Fast Track Designation for heart failure treatment

The drug Farxiga has been granted Fast Track Designation in the US for evaluation in the treatment of heart failure. AstraZeneca has been granted Fast...
Flaccid myelitis: researchers identify antibodies for rare children’s disease

Flaccid myelitis: researchers identify antibodies for rare children’s disease

Protective antibodies for the rare children’s disease – flaccid myelitis – have been identified by researchers, who hope the find could lead to future...
Potential new treatment for skin cancer with wearable patch development

Potential new treatment for skin cancer with wearable patch development

A skin patch development could pave the way for new skin cancer treatments in the future that would not require chemotherapy or radiotherapy. Scientists have...
Experimental cancer drug is potential treatment for rare Rett syndrome

Experimental cancer drug is potential treatment for rare Rett syndrome

Scientists have investigated the use of an experimental cancer drug for the treatment of the rare Rett syndrome, finding that it extended life in...
Could these senolytic drugs halt the spread of COVID-19?

Could these senolytic drugs halt the spread of COVID-19?

Professor Michael Lisanti of Salford University highlights the potential application of senolytic drugs in combating COVID-19. Professor Michael P Lisanti, Chair in Translational Medicine at...
UK companies to supply drugs for major UK COVID-19 drugs trial

UK companies to supply drugs for major UK COVID-19 drugs trial

Four drugs have been announced as the first to be involved with a major COVID-19 drugs trial that will be testing their efficacy for...

Health Special Reports

Health eBooks

Health Partners

Pin It on Pinterest